Anumana, an AI-driven health technology leader and a portfolio company of nference, has announced significant advancements in pulmonary hypertension (PH) diagnosis through its latest study, revealing promising results for its investigational PH algorithm. The study, titled “An electrocardiogram-based AI algorithm for early detection of pulmonary hypertension,” was published in the European Respiratory Journal, showcasing the […]
Nucleai, a provider of artificial intelligence (AI) solutions for pathology and spatial biology, has entered into a strategic collaboration with Mayo Clinic BioPharma Diagnostics. This partnership aims to revolutionize the field of digital pathology by bringing together Nucleai’s AI-powered spatial biology technology and Mayo Clinic’s expertise in longitudinally annotated, multi-modal data sets, lab services, and […]
NurOwn phase 3 trial : BrainStorm Cell Therapeutics, a US biotech company engaged in developing adult stem cell therapies for neurodegenerative diseases, has completed the dosing of all the participants in a phase 3 trial of NurOwn (MSC-NTF cells) in amyotrophic lateral sclerosis (ALS). The late-stage trial enrolled nearly 200 participants, who have been randomized […]
US life sciences company Thermo Fisher Scientific said that it will collaborate with China-based WuXi Diagnostics and Mayo Clinic to develop a total antibodies Covid-19 test called the Thermo Scientific OmniPath COVID-19 Total Antibody ELISA test. The new antibody test development is said to emerge from an ongoing partnership between the three organizations, which includes […]
ImmunogenX, a subsidiary of Immunogenics, has started enrollment of patients for a phase 2b clinical trial to evaluate Latiglutenase (IMGX003), its lead candidate for the treatment of celiac disease. The mid-stage clinical trial, called Solutions for Celiac trial (NCT04243551) is funded by the US’ National Institutes of Health’s (NIH) National Institute of Allergy and Infectious […]
